Texts and brain zaps: new combo for tough depression?
NCT ID NCT05570344
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a supportive text-messaging program (Text4Support) to repetitive transcranial magnetic stimulation (rTMS) improves depression symptoms more than rTMS alone. About 200 adults with treatment-resistant depression will be randomly assigned to one of two groups. The trial lasts 6 weeks of active treatment, with follow-ups at 1, 3, and 6 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Repetitive transcranial magnetic stimulation (rTMS) and Text4Support (supportive text messages)
- What this could lead to
- If it works, this could point toward a more effective, low-cost way to ease depression symptoms in people who haven't responded to standard treatments.
- What could go wrong
- This is a small, early pilot trial, so results may not apply widely. Adding text messages may not provide extra benefit over rTMS alone, and the study is not designed to prove long-term effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * aged 18 and above and diagnosed with MDD based upon the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and who have at least failed two or more standard antidepressant treatments during the current episode. Participants may be on psychotropic medications including antidepressants, antipsychotics, benzodiazepines, and anticonvulsants. They must have a good understanding of the English language. Must have access to a smartphone and be able to receive and read text messages. Must be willing to provide written informed consent upon acceptance into the study. Exclusion Criteria: * Patients below the age of 18. * Having diagnosis such as the following conditions (current unless otherwise stated): A neurological disorder, including a history of seizures, having primary or secondary tumors in the central nervous system, cerebrovascular disease, stroke, cerebral aneurysm, movement disorder, * Having a current psychotic disorder such as substance-induced psychosis, psychotic disorder due to a medical condition, or MDD with psychotic features at the time of screening * Having a current personality disorder that may hinder the patient's participation in this research or may have the potential of affecting cognition and ability to fully participate in the study. * Having a learning disability as per identified through medical history or by the investigator during the assessment process. * Participants involved in any drug or device clinical trial within the last six weeks before the screening visit and/or involvement in another clinical trial for the duration of this study. * Pregnant and breastfeeding women. * Identification and/or the sudden appearance of any condition or instance from the mentioned above and based on the expertise of the investigators that have the potential to hinder the progress and completion and/or become a confounding factor on the outcome assessments.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depressive disorder, treatment-resistant are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Edmonton Mental Health Clinic
RECRUITINGEdmonton, Alberta, T6R 3P5, Canada
-
Nova Scotia Health - Abbie J. Lane Memorial Building QEII Health Sciences Centre
RECRUITINGHalifax, Nova Scotia, B3H 2E2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Brain-Signaling drug crack depression that resists standard treatment?
- One-Day brain zaps: a new hope for stubborn depression?
- Nasal spray could offer new hope for Treatment-Resistant depression
- Experimental depression drug aims to help when standard meds fail
- Laughing gas scans could unlock depression secrets
- Better brain zaps: new study tests precision targeting for depression treatment